SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009022
Filing Date
2016-11-02
Accepted
2016-11-02 09:24:41
Documents
63
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gemp-20160930x10q.htm 10-Q 1763728
2 EX-31.1 gemp-20160930ex311cfe26c.htm EX-31.1 17597
3 EX-31.2 gemp-20160930ex3129a1b7e.htm EX-31.2 17680
4 EX-32.1 gemp-20160930ex321a4f5f1.htm EX-32.1 12024
  Complete submission text file 0001558370-16-009022.txt   5441902

Data Files

Seq Description Document Type Size
5 EX-101.INS gemp-20160930.xml EX-101.INS 784789
6 EX-101.SCH gemp-20160930.xsd EX-101.SCH 45417
7 EX-101.CAL gemp-20160930_cal.xml EX-101.CAL 34259
8 EX-101.DEF gemp-20160930_def.xml EX-101.DEF 220728
9 EX-101.LAB gemp-20160930_lab.xml EX-101.LAB 425087
10 EX-101.PRE gemp-20160930_pre.xml EX-101.PRE 340102
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 161966487
SIC: 2834 Pharmaceutical Preparations